0001921094-24-000318.txt : 20240304 0001921094-24-000318.hdr.sgml : 20240304 20240304182410 ACCESSION NUMBER: 0001921094-24-000318 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 24717147 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 BUSINESS PHONE: 7814399100 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Patel Sanj K CENTRAL INDEX KEY: 0001532218 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 144 1 primary_doc.xml 144 0001532218 XXXXXXXX LIVE 0001730430 Kiniksa Pharmaceuticals, Ltd. 001-38492 CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100 Patel Sanj K Officer Director Common Charles Schwab & Co., Inc.

3000 Schwab Way Westlake TX 76262

83336 1775623.00 39980282 03/04/2024 NASDAQ Common 03/08/2017 Preferred Class B Share Conversion Kiniksa Pharmaceuticals, Ltd. N 83336 03/08/2017 Stock Y The shares covered by this filing, may be sold over various dates. Shares sold in the THE ANGLIA 2013 REVOCABLE TRUST. 03/04/2024 05/05/2023 Sanj K Patel TTEE